erosion, it is not surprising that increases in tooth wear have been positively associated with age 4, 5 ; the longer we maintain our natural teeth, the more likely we are to experience conditions that are commonly associated with dental erosion.
One of the primary factors associated with dental erosion is lifestyle. Lifestyle trends have changed significantly over the past few decades, such as the dramatic increase in the consumption of acidcontaining drinks, particularly soft drinks, energy drinks and sports drinks, and foods. 6, 7 Multiple studies have confirmed significant increases in the consumption of these products. [6] [7] [8] [9] [10] Over the past several decades, we have gained a much better perspective on the ability of daily hygiene practices, particularly those that include fluoride therapy, to help prevent and even reverse, the caries process. [11] [12] [13] Although similar in some aspects, dental erosion is different from caries. Due to the general irreversibility of erosion, many dental professionals are concerned that dental erosion could pose a significant threat to the long-term health and integrity of tooth structure. As a result, preventive strategies designed to protect exposed tooth surfaces against irreversible damage due to dental erosion are of high interest to the dental community. 1, 14 While some fluoride sources have been shown to provide a limited level of erosion protection, stannous fluoride, a multi-benefit active used in some toothpastes, has been shown to provide significant anti-erosion benefits in various types of laboratory studies. [15] [16] [17] [18] There is a growing body of in situ evidence to support the claim that the use of stabilized stannous fluoride dentifrice is an effective means to help control both the initiation and progression of dental erosion in vivo. [19] [20] [21] [22] [23] [24] The study reported here was the first to evaluate a high bioavailable 1100 ppm fluoride stabilized stannous fluoride dentifrice relative to a marketed 1100 ppm fluoride triclosan dentifrice control for erosion protection efficacy using an in situ erosion model with 10-day treatment periods.
| S TUDY P OPUL ATI ON AND ME THODS

| Study population
Healthy male and female participants, 18 years of age or older, were recruited from staff at Bristol University and the Bristol Dental School and Hospital from April to June 2016. A sufficient number of participants were recruited to enrol approximately 36 participants in the study. Potential participants attended a screening visit approximately one month before the start of the study.
Prior to receiving any study specific procedures, participants were asked to read a participant information sheet and sign an informed consent form. Qualified participants were required to have no evidence of the following: susceptibility to acid regurgitation; recurrent or regular aphthous ulcers; dental erosion or a previous history of susceptibility to high dental erosion after drinking sports drinks/juices; excessive gingival inflammation; severe periodontal disease; unremovable mouth or tongue jewellery. Participants had to agree to delay elective dentistry, and to refrain from participation in any other product studies. Participants meeting all study entrance criteria were enrolled in the study and scheduled to return for treatment. 
| Ethical considerations
| Randomization
Participants presented for four study periods and were randomized to one of four treatment sequences by a computer-generated sequence (AABB, BBAA, ABBA or BAAB, where the letters correspond to the two study treatments) that determined the participant's use of one of the two commercially available test dentifrices each period: (a) a highly bioavailable 0.454% stannous fluoride dentifrice (Crest ® Pro-Health™ Advanced Gum Protection, Procter & Gamble, Cincinnati, OH, USA; 1100 ppm fluoride); or (b) a marketed dentifrice control containing 0.24% sodium fluoride and 0.3% triclosan (Colgate ® Total ® , Colgate-Palmolive, New York, NY, USA; 1100 ppm fluoride).
| In situ study design
This was a single centre, double-blind, randomized, two-treatment, four-period crossover study that was a variation of the previously published method of Hooper et al 24 and then spat it out. This procedure was repeated 10 times so that the enamel samples were exposed to a total of 250 mL of orange juice over each 10-minute period of erosive challenge. Each study period was comprised of 10 treatment days, with treatments being done only on weekdays (Monday-Friday) over a span of about 2 weeks. To ensure blinding, the investigator and personnel performing and recording the surface profilometry assessments had no access to the product dispensing room during treatments.
| Preparation and analysis of enamel samples
Prior to the start of the study, profilometry measurements were made on each sample using a calibrated contact surface profilometer (Mitutoyo (UK) Ltd, Andover, Hampshire, UK) to establish a baseline surface profile for each enamel specimen. At the end of the treatment phase of the study, each enamel sample was again measured using the same profilometry method, and tissue loss was calculated.
Fresh samples of human enamel were fitted into the intra-oral appliance at the beginning of each of the four treatment periods. A detailed description of procedures related to the acquisition, sterilization, preparation and analysis of human enamel test specimens has been described previously. 24 
| Determination of sample size
Using 36 participants, at least 80% power to detect a two-sided 5% significant difference between the treatment dentifrices would be achieved provided the natural log scale effect size (mean difference divided by the error standard deviation) was 0.70 or greater for this crossover design.
| Statistical methods
The primary measure of efficacy in the in situ trial was the amount of dental erosion that had occurred, measured by profilometry, The null hypothesis tested at Day 10 in this human in situ clinical study was that the mean dental erosion was equal between the two treatment dentifrices, and the alternative hypothesis was that the mean dental erosion was not equal between the two treatment dentifrices.
| RE SULTS
In this randomized in situ clinical evaluation, 36 participants ranging in age from 20-60 (mean age 40.5 years) were enrolled and 35 were randomized to treatment. Twenty-four (69%) participants F I G U R E 2 Study design with treatment and acid challenge schedule were female. (Table 1 ). Thirty-three (33) participants completed the study, and all study data were deemed evaluable. Three participants dropped due to voluntary withdrawal from the study. At Day 10, the stabilized stannous fluoride dentifrice demonstrated 93.5% less enamel loss (P < 0.0001) vs the NaF/triclosan multi-benefit dentifrice, with estimated enamel loss medians (CI) of 0.097 µm (0.074, 0.127) for the stabilized stannous fluoride dentifrice and 1.495 µm (1.157, 1.931) for the NaF/triclosan dentifrice ( Table 2 ). Distribution Box Plots of enamel loss by treatment ( Figure 3 ) verify distinct differences in performance between the two test dentifrices at Day 10.
Both dentifrices were well tolerated. No significant adverse events were reported.
| D ISCUSS I ON
This study, using 10-day treatment periods, demonstrated a significant erosion protection benefit of 93.5% for the multi-benefit, 1100 ppm fluoride, high bioavailable stabilized stannous fluoride dentifrice compared to the triclosan-containing dentifrice formulated with 1100 ppm fluoride as NaF. These results are consistent with other in situ clinical studies in the literature that have similarly demonstrated enhanced erosion protection, ranging from 27% to 94%, delivered from stabilized stannous fluoride dentifrices compared to other dentifrices that are not formulated with this ingredient. [19] [20] [21] [22] [23] [24] For example, a similar study by West et al 19 found 68% greater erosion protection for a 0.454% stannous fluoride plus 0.077% sodium fluoride (1450 ppm fluoride) dentifrice marketed in the United Kingdom compared to a 1450 ppm fluoride NaF/triclosan dentifrice after 15 days of treatment and a 67% benefit after 10 treatment days. These study results are also consistent with recommendations from professional groups and organizations. 25, 26 A recent consensus report by the European Federation of Conservative Dentistry noted that dentifrices containing stannous fluoride have the potential for slowing erosive tooth wear, while data for other products is limited. 26 Although both dentifrices included in the current study are marketed as being "multi-benefit" products, protection against dental erosion is determined, in part, by the ability of a dentifrice to deposit a protective, acid-resistant barrier layer onto the surface of treated teeth. Stabilized stannous fluoride is capable of depositing such a layer. Mechanism of action studies found that stannous fluoride provides erosion benefits through the deposition of a transparent, protective barrier layer onto the enamel surface that provides enhanced resistance against erosive acid challenges. 16, 17, 27 Figure 4 shows images of etched enamel slabs treated with stannous fluoride, sodium fluoride, sodium monofluorophosphate or amine fluoride slurries and stained with 2% alizarin Red-S. 28 The slab treated with stannous fluoride showed little evidence of staining with the dye, indicating that it had formed a surface layer that protected against dye deposition. Stannous fluoride is able to incorporate onto both smooth and pellicle-coated surfaces. The barrier layer that forms on pellicle-coated enamel, likely composed of metal-rich precipitates such as Sn 3 F 3 PO 4 , Ca(SnF 3 ) 2 or SnOHPO 4 , 29,30 increases with continued use and is retained on treated tooth surfaces for extended periods of time, strengthening the enamel surface against subsequent acid attacks. 16, 27 Early stannous fluoride formulations were associated with the potential for surface stain, but contemporary formulas contain stain-mitigating ingredients, such as the sodium hexametaphosphate in this formula, that can actually provide extrinsic whitening. 31, 32 One might argue the erosion protection benefits of oral care products should be demonstrated in long-term human erosion clinical studies; however, given the slow progression of the condition, the general irreversibility of dental erosion and ethical considerations, such studies are impractical. Properly controlled in situ studies provide a reasonable clinical alternative for assessing relative erosion protection performance in relatively short periods of time, while minimizing the risk to participants' natural tooth surfaces.
While dental erosion follows a path that is, in some ways, similar to the demineralization aspects of caries (ie, tooth mineral is lost due to an acid challenge), dental erosion is different; it primarily occurs as a loss of surface, rather than subsurface mineral. 1 This key factor makes it far more difficult to restore lost mineral through the remineralization process. Although remineralization via fluoride therapy can present an almost constant abrasive factor, as it comes into contact with exposed tooth surfaces on a routine basis. 33, 34 The goal of any product intended to help prevent dental erosion is to maintain the integrity of the sound enamel surface. The in the current study, with the differences between the two test products being highly significant.
| CON CLUS ION
The stannous fluoride dentifrice included in this randomized in situ clinical trial demonstrated significantly greater erosion protection F I G U R E 3 Box plot of data showing individual and averaged enamel loss data points for each of the two test dentifrices F I G U R E 4 Dye deposition on acid etched enamel samples following treatment with toothpaste/saliva slurry. Samples were treated with a toothpaste/saliva slurry (1100 ppm stannous fluoride, 1100 ppm sodium fluoride, 1000 ppm sodium monofluorophosphate or 1400 ppm amine fluoride) and exposed to 2% alizarin Red-S following rinsing. Dye deposition was evaluated using a 5-point scale; 0 indicates no dye deposition and 4 indicates complete dye coverage. A low score signifies the presence of a barrier layer preventing dye deposition 28 efficacy relative to the NaF/triclosan dentifrice. The use of a clinically proven stannous fluoride dentifrice is both a convenient and economical way to incorporate a preventive strategy for dental erosion into patients' daily oral hygiene regimen.
| CLINIC AL RELE VAN CE
| Scientific rationale for study
Dental erosion is a growing global oral care issue, and stabilized stannous fluoride dentifrices have been consistently proven to help control both the initiation and progression of this condition better than other tested products.
| Principal findings
This in situ clinical study demonstrated greater erosion protection potential of a stabilized stannous fluoride dentifrice compared to a NaF/triclosan dentifrice.
| Practical implications
Stabilized stannous fluoride dentifrices should be strongly recommended as part of a comprehensive daily oral hygiene plan, especially for those patients at risk of developing dental erosion.
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